| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Other | Common Stock | 2.2M | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Other | Common Stock | 414.6k | $0.00 | $0 | See Footnotes | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Other | Common Stock | 2.5k | $0.00 | $0 | See Footnotes | 01/03/2023 |
| 01/03/2023 | Oyster Point Pharma, Inc. | OYST | Other | Common Stock | 1M | $0.00 | $0 | See Footnotes | 01/03/2023 |
| 08/09/2022 | Century Therapeutics, Inc. | | Sale | Common Stock | 550k | $13.03 | $7.2M | | 08/09/2022 |
| 08/09/2022 | Century Therapeutics, Inc. | | Other (disposition) | Common Stock | 364.8k | $0.00 | $0 | | 08/09/2022 |
| 01/31/2022 | Century Therapeutics, Inc. | | Other (disposition) | Common Stock | 179k | $0.00 | $0 | | 01/31/2022 |
| 01/05/2022 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 200.2k | $0.00 | $0 | See Footnotes | 01/05/2022 |
| 01/05/2022 | Oyster Point Pharma, Inc. | OYST | Other (acquisition) | Common Stock | 51.6k | $0.00 | $0 | See Footnotes | 01/05/2022 |
| 01/05/2022 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 51.6k | $0.00 | $0 | See Footnotes | 01/05/2022 |
| 01/05/2022 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 1.3k | $0.00 | $0 | See Footnotes | 01/05/2022 |
| 12/23/2021 | Century Therapeutics, Inc. | | Other (disposition) | Common Stock | 371k | $0.00 | $0 | | 12/23/2021 |
| 12/21/2021 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 200.2k | $0.00 | $0 | See Footnotes | 12/21/2021 |
| 12/21/2021 | Oyster Point Pharma, Inc. | OYST | Other (acquisition) | Common Stock | 51.6k | $0.00 | $0 | See Footnotes | 12/21/2021 |
| 12/21/2021 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 51.6k | $0.00 | $0 | See Footnotes | 12/21/2021 |
| 12/21/2021 | Oyster Point Pharma, Inc. | OYST | Other (disposition) | Common Stock | 1.3k | $0.00 | $0 | See Footnotes | 12/21/2021 |
| 10/18/2021 | Oyster Point Pharma, Inc. | OYST | Sale | Common Stock | 303.6k | $14.63 | $4.4M | See Footnotes | 10/18/2021 |
| 10/18/2021 | Oyster Point Pharma, Inc. | OYST | Sale | Common Stock | 1.9k | $14.63 | $28k | See Footnotes | 10/18/2021 |
| 10/18/2021 | Oyster Point Pharma, Inc. | OYST | Sale | Common Stock | 242.9k | $15.09 | $3.7M | See Footnotes | 10/18/2021 |
| 10/18/2021 | Oyster Point Pharma, Inc. | OYST | Sale | Common Stock | 1.5k | $15.09 | $23.1k | See Footnotes | 10/18/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Common Stock | 12.3M | $0.00 | $0 | | 06/29/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Common Stock | 1.5M | $0.00 | $0 | See footnote | 06/29/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Purchase | Common Stock | 180k | $17.00 | $3.1M | See footnote | 06/29/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Series A Preferred Stock | 30M | $0.00 | $0 | | 06/29/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Series B Preferred Stock | 3.7M | $0.00 | $0 | See footnote | 06/29/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Common Stock | 6.5M | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Common Stock | 1.9M | $0.00 | $0 | By Versant Vantage I, L.P. | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Purchase | Common Stock | 157.9k | $19.00 | $3M | By Versant Vantage I, L.P. | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series A convertible preferred stock | 20M | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series B convertible preferred stock | 3M | $0.00 | $0 | | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series B convertible preferred stock | 4.2M | $0.00 | $0 | By Versant Vantage I, L.P. | 06/28/2021 |
| 06/28/2021 | Monte Rosa Therapeutics, Inc. | | Conversion | Series C convertible preferred stock | 2.7M | $0.00 | $0 | By Versant Vantage I, L.P. | 06/28/2021 |
| 06/22/2021 | Century Therapeutics, Inc. | | Conversion | Common Stock | 9.9M | $0.00 | $0 | | 06/22/2021 |
| 06/22/2021 | Century Therapeutics, Inc. | | Conversion | Common Stock | 614.1k | $0.00 | $0 | See footnote | 06/22/2021 |
| 06/22/2021 | Century Therapeutics, Inc. | | Purchase | Common Stock | 100k | $20.00 | $2M | See footnote | 06/22/2021 |
|